SrasV1, PubMed, Curation, bibRecord, 001B61

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

Identifieur interne : 001B61 ( PubMed/Curation ); précédent : 001B60; suivant : 001B62

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

Auteurs : Noton Kumar Dutta [Corée du Sud] ; Kaushiki Mazumdar ; Byoung-Hee Lee ; Min-Won Baek ; Dong-Jae Kim ; Yi-Rang Na ; Sung-Hoon Park ; Hyun-Kyoung Lee ; Hiroaki Kariwa ; Le Quynh Mai ; Jae-Hak Park

Source :

Immunology letters [ 0165-2478 ] ; 2008.

RBID : pubmed:18440652

Descripteurs français

KwdFr :
- Animaux, Anticorps (immunologie), Escherichia coli (génétique), Escherichia coli (métabolisme), Femelle, Humains, Lignée cellulaire, Lymphocytes T (cytologie), Lymphocytes T (immunologie), Nucléocapside (génétique), Nucléocapside (immunologie), Nucléocapside (métabolisme), Prolifération cellulaire, Souris, Souris de lignée BALB C, Vaccins antiviraux (génétique), Vaccins antiviraux (immunologie), Vaccins antiviraux (métabolisme), Vaccins à ADN (génétique), Vaccins à ADN (immunologie), Vaccins à ADN (métabolisme), Virus du SRAS (génétique), Virus du SRAS (immunologie), Virus du SRAS (métabolisme), Épitopes (immunologie).
MESH :
- cytologie : Lymphocytes T.
- génétique : Escherichia coli, Nucléocapside, Vaccins antiviraux, Vaccins à ADN, Virus du SRAS.
- immunologie : Anticorps, Lymphocytes T, Nucléocapside, Vaccins antiviraux, Vaccins à ADN, Virus du SRAS, Épitopes.
- métabolisme : Escherichia coli, Nucléocapside, Vaccins antiviraux, Vaccins à ADN, Virus du SRAS.
- Animaux, Femelle, Humains, Lignée cellulaire, Prolifération cellulaire, Souris, Souris de lignée BALB C.

English descriptors

KwdEn :
- Animals, Antibodies (immunology), Cell Line, Cell Proliferation, Epitopes (immunology), Escherichia coli (genetics), Escherichia coli (metabolism), Female, Humans, Mice, Mice, Inbred BALB C, Nucleocapsid (genetics), Nucleocapsid (immunology), Nucleocapsid (metabolism), SARS Virus (genetics), SARS Virus (immunology), SARS Virus (metabolism), T-Lymphocytes (cytology), T-Lymphocytes (immunology), Vaccines, DNA (genetics), Vaccines, DNA (immunology), Vaccines, DNA (metabolism), Viral Vaccines (genetics), Viral Vaccines (immunology), Viral Vaccines (metabolism).
MESH :
- chemical , genetics : Vaccines, DNA, Viral Vaccines.
- chemical , immunology : Antibodies, Epitopes, Vaccines, DNA, Viral Vaccines.
- cytology : T-Lymphocytes.
- genetics : Escherichia coli, Nucleocapsid, SARS Virus.
- immunology : Nucleocapsid, SARS Virus, T-Lymphocytes.
- metabolism : Escherichia coli, Nucleocapsid, SARS Virus, Vaccines, DNA, Viral Vaccines.
- Animals, Cell Line, Cell Proliferation, Female, Humans, Mice, Mice, Inbred BALB C.

Abstract

It is believed today that nucleocapsid protein (N) of severe acute respiratory syndrome (SARS)-CoV is one of the most promising antigen candidates for vaccine design. In this study, three fragments [N1 (residues: 1-422); N2 (residues: 1-109); N3 (residues: 110-422)] of N protein of SARS-CoV were expressed in Escherichia coli and analyzed by pooled sera of convalescence phase of SARS patients. Three gene fragments [N1 (1-1269 nt), N2 (1-327 nt) and N3 (328-1269 nt)-expressing the same proteins of N1, N2 and N3, respectively] of SARS-N were cloned into pVAX-1 and used to immunize BALB/c mice by electroporation. Humoral (by enzyme-linked immunosorbent assay, ELISA) and cellular (by cell proliferation and CD4(+):CD8(+) assay) immunity was detected by using recombinant N1 and N3 specific antigen. Results showed that N1 and N3 fragments of N protein expressed by E. coli were able to react with sera of SARS patients but N2 could not. Specific humoral and cellular immunity in mice could be induced significantly by inoculating SARS-CoV N1 and N3 DNA vaccine. In addition, the immune response levels in N3 were significantly higher for antibody responses (IgG and IgG1 but not IgG2a) and cell proliferation but not in CD4(+):CD8(+) assay compared to N1 vaccine. The identification of antigenic N protein fragments has implications to provide basic information for the design of DNA vaccine against SARS-CoV. The present results not only suggest that DNA immunization with pVax-N3 could be used as potential DNA vaccination approaches to induce antibody in BALB/c mice, but also illustrates that gene immunization with these SARS DNA vaccines can generate different immune responses.

DOI: 10.1016/j.imlet.2008.03.003
PubMed: 18440652

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B61

Links to Exploration step

pubmed:18440652

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.</title>
<author><name sortKey="Dutta, Noton Kumar" sort="Dutta, Noton Kumar" uniqKey="Dutta N" first="Noton Kumar" last="Dutta">Noton Kumar Dutta</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory Animal Medicine, College of Veterinary Medicine and KRF Zoonotic Disease Priority Research Institute, Seoul National University, Gwanak-Gu, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Laboratory Animal Medicine, College of Veterinary Medicine and KRF Zoonotic Disease Priority Research Institute, Seoul National University, Gwanak-Gu, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mazumdar, Kaushiki" sort="Mazumdar, Kaushiki" uniqKey="Mazumdar K" first="Kaushiki" last="Mazumdar">Kaushiki Mazumdar</name>
</author>
<author><name sortKey="Lee, Byoung Hee" sort="Lee, Byoung Hee" uniqKey="Lee B" first="Byoung-Hee" last="Lee">Byoung-Hee Lee</name>
</author>
<author><name sortKey="Baek, Min Won" sort="Baek, Min Won" uniqKey="Baek M" first="Min-Won" last="Baek">Min-Won Baek</name>
</author>
<author><name sortKey="Kim, Dong Jae" sort="Kim, Dong Jae" uniqKey="Kim D" first="Dong-Jae" last="Kim">Dong-Jae Kim</name>
</author>
<author><name sortKey="Na, Yi Rang" sort="Na, Yi Rang" uniqKey="Na Y" first="Yi-Rang" last="Na">Yi-Rang Na</name>
</author>
<author><name sortKey="Park, Sung Hoon" sort="Park, Sung Hoon" uniqKey="Park S" first="Sung-Hoon" last="Park">Sung-Hoon Park</name>
</author>
<author><name sortKey="Lee, Hyun Kyoung" sort="Lee, Hyun Kyoung" uniqKey="Lee H" first="Hyun-Kyoung" last="Lee">Hyun-Kyoung Lee</name>
</author>
<author><name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
</author>
<author><name sortKey="Mai, Le Quynh" sort="Mai, Le Quynh" uniqKey="Mai L" first="Le Quynh" last="Mai">Le Quynh Mai</name>
</author>
<author><name sortKey="Park, Jae Hak" sort="Park, Jae Hak" uniqKey="Park J" first="Jae-Hak" last="Park">Jae-Hak Park</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18440652</idno>
<idno type="pmid">18440652</idno>
<idno type="doi">10.1016/j.imlet.2008.03.003</idno>
<idno type="wicri:Area/PubMed/Corpus">001B61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B61</idno>
<idno type="wicri:Area/PubMed/Curation">001B61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B61</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.</title>
<author><name sortKey="Dutta, Noton Kumar" sort="Dutta, Noton Kumar" uniqKey="Dutta N" first="Noton Kumar" last="Dutta">Noton Kumar Dutta</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory Animal Medicine, College of Veterinary Medicine and KRF Zoonotic Disease Priority Research Institute, Seoul National University, Gwanak-Gu, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Laboratory Animal Medicine, College of Veterinary Medicine and KRF Zoonotic Disease Priority Research Institute, Seoul National University, Gwanak-Gu, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mazumdar, Kaushiki" sort="Mazumdar, Kaushiki" uniqKey="Mazumdar K" first="Kaushiki" last="Mazumdar">Kaushiki Mazumdar</name>
</author>
<author><name sortKey="Lee, Byoung Hee" sort="Lee, Byoung Hee" uniqKey="Lee B" first="Byoung-Hee" last="Lee">Byoung-Hee Lee</name>
</author>
<author><name sortKey="Baek, Min Won" sort="Baek, Min Won" uniqKey="Baek M" first="Min-Won" last="Baek">Min-Won Baek</name>
</author>
<author><name sortKey="Kim, Dong Jae" sort="Kim, Dong Jae" uniqKey="Kim D" first="Dong-Jae" last="Kim">Dong-Jae Kim</name>
</author>
<author><name sortKey="Na, Yi Rang" sort="Na, Yi Rang" uniqKey="Na Y" first="Yi-Rang" last="Na">Yi-Rang Na</name>
</author>
<author><name sortKey="Park, Sung Hoon" sort="Park, Sung Hoon" uniqKey="Park S" first="Sung-Hoon" last="Park">Sung-Hoon Park</name>
</author>
<author><name sortKey="Lee, Hyun Kyoung" sort="Lee, Hyun Kyoung" uniqKey="Lee H" first="Hyun-Kyoung" last="Lee">Hyun-Kyoung Lee</name>
</author>
<author><name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
</author>
<author><name sortKey="Mai, Le Quynh" sort="Mai, Le Quynh" uniqKey="Mai L" first="Le Quynh" last="Mai">Le Quynh Mai</name>
</author>
<author><name sortKey="Park, Jae Hak" sort="Park, Jae Hak" uniqKey="Park J" first="Jae-Hak" last="Park">Jae-Hak Park</name>
</author>
</analytic>
<series><title level="j">Immunology letters</title>
<idno type="ISSN">0165-2478</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies (immunology)</term>
<term>Cell Line</term>
<term>Cell Proliferation</term>
<term>Epitopes (immunology)</term>
<term>Escherichia coli (genetics)</term>
<term>Escherichia coli (metabolism)</term>
<term>Female</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Nucleocapsid (genetics)</term>
<term>Nucleocapsid (immunology)</term>
<term>Nucleocapsid (metabolism)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (metabolism)</term>
<term>T-Lymphocytes (cytology)</term>
<term>T-Lymphocytes (immunology)</term>
<term>Vaccines, DNA (genetics)</term>
<term>Vaccines, DNA (immunology)</term>
<term>Vaccines, DNA (metabolism)</term>
<term>Viral Vaccines (genetics)</term>
<term>Viral Vaccines (immunology)</term>
<term>Viral Vaccines (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps (immunologie)</term>
<term>Escherichia coli (génétique)</term>
<term>Escherichia coli (métabolisme)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphocytes T (cytologie)</term>
<term>Lymphocytes T (immunologie)</term>
<term>Nucléocapside (génétique)</term>
<term>Nucléocapside (immunologie)</term>
<term>Nucléocapside (métabolisme)</term>
<term>Prolifération cellulaire</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Vaccins antiviraux (génétique)</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vaccins antiviraux (métabolisme)</term>
<term>Vaccins à ADN (génétique)</term>
<term>Vaccins à ADN (immunologie)</term>
<term>Vaccins à ADN (métabolisme)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (immunologie)</term>
<term>Virus du SRAS (métabolisme)</term>
<term>Épitopes (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Vaccines, DNA</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies</term>
<term>Epitopes</term>
<term>Vaccines, DNA</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Escherichia coli</term>
<term>Nucleocapsid</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Escherichia coli</term>
<term>Nucléocapside</term>
<term>Vaccins antiviraux</term>
<term>Vaccins à ADN</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps</term>
<term>Lymphocytes T</term>
<term>Nucléocapside</term>
<term>Vaccins antiviraux</term>
<term>Vaccins à ADN</term>
<term>Virus du SRAS</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Nucleocapsid</term>
<term>SARS Virus</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Escherichia coli</term>
<term>Nucleocapsid</term>
<term>SARS Virus</term>
<term>Vaccines, DNA</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Escherichia coli</term>
<term>Nucléocapside</term>
<term>Vaccins antiviraux</term>
<term>Vaccins à ADN</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Cell Proliferation</term>
<term>Female</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Prolifération cellulaire</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">It is believed today that nucleocapsid protein (N) of severe acute respiratory syndrome (SARS)-CoV is one of the most promising antigen candidates for vaccine design. In this study, three fragments [N1 (residues: 1-422); N2 (residues: 1-109); N3 (residues: 110-422)] of N protein of SARS-CoV were expressed in Escherichia coli and analyzed by pooled sera of convalescence phase of SARS patients. Three gene fragments [N1 (1-1269 nt), N2 (1-327 nt) and N3 (328-1269 nt)-expressing the same proteins of N1, N2 and N3, respectively] of SARS-N were cloned into pVAX-1 and used to immunize BALB/c mice by electroporation. Humoral (by enzyme-linked immunosorbent assay, ELISA) and cellular (by cell proliferation and CD4(+):CD8(+) assay) immunity was detected by using recombinant N1 and N3 specific antigen. Results showed that N1 and N3 fragments of N protein expressed by E. coli were able to react with sera of SARS patients but N2 could not. Specific humoral and cellular immunity in mice could be induced significantly by inoculating SARS-CoV N1 and N3 DNA vaccine. In addition, the immune response levels in N3 were significantly higher for antibody responses (IgG and IgG1 but not IgG2a) and cell proliferation but not in CD4(+):CD8(+) assay compared to N1 vaccine. The identification of antigenic N protein fragments has implications to provide basic information for the design of DNA vaccine against SARS-CoV. The present results not only suggest that DNA immunization with pVax-N3 could be used as potential DNA vaccination approaches to induce antibody in BALB/c mice, but also illustrates that gene immunization with these SARS DNA vaccines can generate different immune responses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18440652</PMID>
<DateCompleted><Year>2008</Year>
<Month>08</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0165-2478</ISSN>
<JournalIssue CitedMedium="Print"><Volume>118</Volume>
<Issue>1</Issue>
<PubDate><Year>2008</Year>
<Month>Jun</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Immunology letters</Title>
<ISOAbbreviation>Immunol. Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.</ArticleTitle>
<Pagination><MedlinePgn>65-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imlet.2008.03.003</ELocationID>
<Abstract><AbstractText>It is believed today that nucleocapsid protein (N) of severe acute respiratory syndrome (SARS)-CoV is one of the most promising antigen candidates for vaccine design. In this study, three fragments [N1 (residues: 1-422); N2 (residues: 1-109); N3 (residues: 110-422)] of N protein of SARS-CoV were expressed in Escherichia coli and analyzed by pooled sera of convalescence phase of SARS patients. Three gene fragments [N1 (1-1269 nt), N2 (1-327 nt) and N3 (328-1269 nt)-expressing the same proteins of N1, N2 and N3, respectively] of SARS-N were cloned into pVAX-1 and used to immunize BALB/c mice by electroporation. Humoral (by enzyme-linked immunosorbent assay, ELISA) and cellular (by cell proliferation and CD4(+):CD8(+) assay) immunity was detected by using recombinant N1 and N3 specific antigen. Results showed that N1 and N3 fragments of N protein expressed by E. coli were able to react with sera of SARS patients but N2 could not. Specific humoral and cellular immunity in mice could be induced significantly by inoculating SARS-CoV N1 and N3 DNA vaccine. In addition, the immune response levels in N3 were significantly higher for antibody responses (IgG and IgG1 but not IgG2a) and cell proliferation but not in CD4(+):CD8(+) assay compared to N1 vaccine. The identification of antigenic N protein fragments has implications to provide basic information for the design of DNA vaccine against SARS-CoV. The present results not only suggest that DNA immunization with pVax-N3 could be used as potential DNA vaccination approaches to induce antibody in BALB/c mice, but also illustrates that gene immunization with these SARS DNA vaccines can generate different immune responses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dutta</LastName>
<ForeName>Noton Kumar</ForeName>
<Initials>NK</Initials>
<AffiliationInfo><Affiliation>Laboratory Animal Medicine, College of Veterinary Medicine and KRF Zoonotic Disease Priority Research Institute, Seoul National University, Gwanak-Gu, Seoul, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mazumdar</LastName>
<ForeName>Kaushiki</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Byoung-Hee</ForeName>
<Initials>BH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Baek</LastName>
<ForeName>Min-Won</ForeName>
<Initials>MW</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Dong-Jae</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Na</LastName>
<ForeName>Yi-Rang</ForeName>
<Initials>YR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Park</LastName>
<ForeName>Sung-Hoon</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Hyun-Kyoung</ForeName>
<Initials>HK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kariwa</LastName>
<ForeName>Hiroaki</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mai</LastName>
<ForeName>Le Quynh</ForeName>
<Initials>le Q</Initials>
</Author>
<Author ValidYN="Y"><LastName>Park</LastName>
<ForeName>Jae-Hak</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2008</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Immunol Lett</MedlineTA>
<NlmUniqueID>7910006</NlmUniqueID>
<ISSNLinking>0165-2478</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000906">Antibodies</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019444">Vaccines, DNA</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019251" MajorTopicYN="N">Nucleocapsid</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019444" MajorTopicYN="N">Vaccines, DNA</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>01</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2008</Year>
<Month>03</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2008</Year>
<Month>03</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>4</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>4</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18440652</ArticleId>
<ArticleId IdType="pii">S0165-2478(08)00087-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.imlet.2008.03.003</ArticleId>
<ArticleId IdType="pmc">PMC7112843</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Avian Pathol. 2003 Dec;32(6):567-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14676007</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2001 Nov 28;80(1-2):75-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11597750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Microbiol. 2003 Sep;11(9):438-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13678860</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Immunol Lett. 2004 Apr 15;92(3):237-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15081618</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 Mar;77(5):2922-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12584316</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gene Med. 1999 May-Jun;1(3):186-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10738567</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):338-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15170626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2006 Mar 30;347(1):127-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16387339</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>New Microbiol. 2003 Apr;26(2):151-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12737196</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Jul 15;190(2):379-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15216476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 May 14;317(4):1030-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15094372</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Feb 20;314(4):931-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14751221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Can J Vet Res. 2002 Oct;66(4):278-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12418784</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol Methods. 1999 Jul 30;227(1-2):85-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10485257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Chem. 2004 Jun;50(6):988-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15054081</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 May;78(9):4638-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078946</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1377-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12775826</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2004 Mar;11(2):362-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15013989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 May;76(10):4987-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11967315</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 2004 May;42(5):2306-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15131220</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Dev Biol (Basel). 2004;119:129-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15742624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2005 Mar 18;23(17-18):2269-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15755609</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mol Immunol. 2006 Apr;43(11):1791-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16423399</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2005 Oct 14;336(1):110-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16112641</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2004 May 25;43(20):6059-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Dec 6;362(9399):1895-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14667748</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol Methods. 2005 Sep;128(1-2):21-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15885812</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2000 May 1;164(9):4635-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10779767</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 1995;380:197-211</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8830481</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1990 Nov;179(1):463-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2171216</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B61 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001B61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:18440652
   |texte=   Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:18440652" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki